Literature DB >> 24878698

Overexpression of Dickkopf-1 predicts poor prognosis for patients with hepatocellular carcinoma after orthotopic liver transplantation by promoting cancer metastasis and recurrence.

Yan Huang1, Xinrong Yang, Fengbo Zhao, Qiujin Shen, Zhiwei Wang, Xiufang Lv, Baoying Hu, Bin Yu, Jia Fan, Wenxin Qin.   

Abstract

Our previous data had shown that Dickkopf-1 (DKK1) combined with β-catenin was a novel prognostic predictor for hepatocellular carcinoma (HCC) patients. However, the role and mechanism of DKK1 in HCC recurrence or metastasis remain poorly understand. This study was to assess the role of DKK1 in tumor metastasis for patients with hepatocellular carcinoma after orthotopic liver transplantation (OLT). The expression of DKK1 protein was detected in hepatic cell lines, HCC cell lines, and HCC patients after OLT with different potential of metastasis. After DKK1 expression in the HCCLM3 cells was downregulated by siRNA-mediated approach, the role of DKK1 in cell invasion and metastasis was investigated. cDNA genechip was used to analyze the differential expressed genes related with DKK1 in two pairs of HCC cells. The prognostic significance of DKK1 was further assessed by Kaplan-Meier and Cox regression analyses in 148 HCC patients after OLT. The expression of DKK1 protein was higher in the high-invasive HCC cells and HCC patients of the disease recurrence group. With the downregulation of DKK1, HCCLM3 cells showed decreased aggressiveness in vitro and lower metastatic ability in vivo. DKK1 could regulate many genes involved in biological processes and pathways related with tumor progression. Furthermore, DKK1 overexpression correlated with tumor microvessel density in clinical HCC samples. Multivariate analysis revealed that DKK1 was an independent prognostic indicator for overall survival and cumulative recurrence in this cohort of HCC patients post-OLT. Collectively, overexpression of DKK1 was implicated in invasion/metastasis of HCC after OLT and DKK1 overexpression may be potential molecular therapeutic targets for liver cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24878698     DOI: 10.1007/s12032-014-0966-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  31 in total

1.  Elevated expression of Wnt antagonists is a common event in hepatoblastomas.

Authors:  Arend Koch; Andreas Waha; Wolfgang Hartmann; Aksana Hrychyk; Ulrich Schüller; Anke Waha; Keith A Wharton; Serge Y Fuchs; Dietrich von Schweinitz; Torsten Pietsch
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

2.  Expression of Dickkopf genes is strongly reduced in malignant melanoma.

Authors:  S Kuphal; S Lodermeyer; F Bataille; M Schuierer; B H Hoang; A K Bosserhoff
Journal:  Oncogene       Date:  2006-03-27       Impact factor: 9.867

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction.

Authors:  A Glinka; W Wu; H Delius; A P Monaghan; C Blumenstock; C Niehrs
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

5.  Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Authors:  Nagato Sato; Takumi Yamabuki; Atsushi Takano; Junkichi Koinuma; Masato Aragaki; Ken Masuda; Nobuhisa Ishikawa; Nobuoki Kohno; Hiroyuki Ito; Masaki Miyamoto; Haruhiko Nakayama; Yohei Miyagi; Eiju Tsuchiya; Satoshi Kondo; Yusuke Nakamura; Yataro Daigo
Journal:  Cancer Res       Date:  2010-06-15       Impact factor: 12.701

Review 6.  Role of Wnts in prostate cancer bone metastases.

Authors:  Christopher L Hall; Sona Kang; Ormond A MacDougald; Evan T Keller
Journal:  J Cell Biochem       Date:  2006-03-01       Impact factor: 4.429

7.  Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth.

Authors:  Nobuyasu Takahashi; Tsuyoshi Fukushima; Kenji Yorita; Hiroyuki Tanaka; Kazuo Chijiiwa; Hiroaki Kataoka
Journal:  Int J Cancer       Date:  2010-04-01       Impact factor: 7.396

Review 8.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

9.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Authors:  O Aguilera; M F Fraga; E Ballestar; M F Paz; M Herranz; J Espada; J M García; A Muñoz; M Esteller; J M González-Sancho
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

10.  Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas.

Authors:  Takumi Yamabuki; Atsushi Takano; Satoshi Hayama; Nobuhisa Ishikawa; Tatsuya Kato; Masaki Miyamoto; Tomoo Ito; Hiroyuki Ito; Yohei Miyagi; Haruhiko Nakayama; Masahiro Fujita; Masao Hosokawa; Eiju Tsuchiya; Nobuoki Kohno; Satoshi Kondo; Yusuke Nakamura; Yataro Daigo
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

View more
  21 in total

Review 1.  Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.

Authors:  Kerstin Schütte; Christian Schulz; Alexander Link; Peter Malfertheiner
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.

Authors:  Pei-Pei Song; Ju-Feng Xia; Yoshinori Inagaki; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Norihiro Kokudo; Wei Tang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Study of Dickkopf-1 (DKK-1) Gene Expression in Hepatocellular Carcinoma Patients.

Authors:  Mona Watany; Rehab Badawi; Walaa Elkhalawany; Sherief Abd-Elsalam
Journal:  J Clin Diagn Res       Date:  2017-02-01

4.  Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?

Authors:  Maria E Lozada; Roongruedee Chaiteerakij; Lewis R Roberts
Journal:  Curr Hepatol Rep       Date:  2015-06

5.  High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomy.

Authors:  Qiujin Shen; Xin-Rong Yang; Yexiong Tan; Haiyan You; Yang Xu; Wei Chu; Tianxiang Ge; Jian Zhou; Shuang-Jian Qiu; Ying-Hong Shi; Zhigang Zhang; Jianren Gu; Hongyang Wang; Jia Fan; Wenxin Qin
Journal:  Hepat Oncol       Date:  2015-04-01

6.  Serum dickkopf-1 as a biomarker in screening gastrointestinal cancers: a systematic review and meta-analysis.

Authors:  Bin Liang; Liansheng Zhong; Qun He; Shaocheng Wang; Zhongcheng Pan; Tianjiao Wang; Yujie Zhao
Journal:  Onco Targets Ther       Date:  2015-10-22       Impact factor: 4.147

7.  Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.

Authors:  Óscar Aguilera; José Manuel González-Sancho; Sandra Zazo; Raúl Rincón; Agustín F Fernández; Olga Tapia; Francesc Canals; Beatriz Morte; Vincenzo Calvanese; José L Orgaz; Núria Niell; Susana Aguilar; José M Freije; Osvaldo Graña; David G Pisano; Aurea Borrero; Javier Martínez-Useros; Benilde Jiménez; Mario F Fraga; Jesús García-Foncillas; Carlos López-Otín; Miguel Lafarga; Federico Rojo; Alberto Muñoz
Journal:  Oncotarget       Date:  2015-03-20

8.  Different Astrocytic Activation between Adult Gekko japonicus and Rats during Wound Healing In Vitro.

Authors:  Yun Gu; Jian Yang; Haijiao Chen; Jing Li; Man Xu; Juan Hua; Jian Yao; Yongjun Wang; Yan Liu; Mei Liu
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

9.  Stratifin accelerates progression of lung adenocarcinoma at an early stage.

Authors:  Aya Shiba-Ishii; Yunjung Kim; Toshihiro Shiozawa; Shinji Iyama; Kaishi Satomi; Junko Kano; Shingo Sakashita; Yukio Morishita; Masayuki Noguchi
Journal:  Mol Cancer       Date:  2015-07-30       Impact factor: 27.401

10.  Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma.

Authors:  Yung-Hao Wong; Chia-Chou Wu; Chih-Lung Lin; Ting-Shou Chen; Tzu-Hao Chang; Bor-Sen Chen
Journal:  Biomed Res Int       Date:  2015-08-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.